Volume 34, Issue 2, Pages (February 2011)

Slides:



Advertisements
Similar presentations
Volume 34, Issue 5, Pages (May 2011)
Advertisements

Volume 33, Issue 2, Pages (August 2010)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 42, Issue 3, Pages (March 2015)
Volume 25, Issue 2, Pages (August 2006)
Volume 33, Issue 3, Pages (September 2010)
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development  Weiming Ouyang, Omar Beckett, Qian Ma,
Volume 137, Issue 3, Pages (September 2009)
Volume 35, Issue 4, Pages (October 2011)
Volume 31, Issue 2, Pages (August 2009)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 45, Issue 1, Pages (July 2016)
Volume 33, Issue 1, Pages (July 2010)
Volume 42, Issue 5, Pages (May 2015)
Volume 31, Issue 5, Pages (November 2009)
Volume 137, Issue 3, Pages (September 2009)
Volume 32, Issue 5, Pages (May 2010)
Ananda W Goldrath, Michael J Bevan  Immunity 
Depletion of Host CCR7+ Dendritic Cells Prevented Donor T Cell Tissue Tropism in Anti- CD3–Conditioned Recipients  Wei He, Jeremy J. Racine, Heather F.
Volume 141, Issue 5, Pages (November 2011)
Volume 28, Issue 4, Pages (April 2008)
Volume 40, Issue 4, Pages (April 2014)
Cross-Differentiation from the CD8 Lineage to CD4 T Cells in the Gut-Associated Microenvironment with a Nonessential Role of Microbiota  Jen Bon Lui,
Volume 33, Issue 2, Pages (August 2010)
Volume 25, Issue 3, Pages (September 2006)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Volume 33, Issue 3, Pages (September 2010)
Volume 21, Issue 3, Pages (September 2004)
Volume 29, Issue 1, Pages (July 2008)
Volume 29, Issue 5, Pages (November 2008)
Volume 31, Issue 5, Pages (November 2009)
Volume 29, Issue 1, Pages (July 2008)
Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4  James Badger Wing, Wataru.
Volume 29, Issue 6, Pages (December 2008)
Volume 33, Issue 5, Pages (November 2010)
Volume 31, Issue 5, Pages (November 2009)
Volume 36, Issue 2, Pages (February 2012)
Volume 34, Issue 4, Pages (April 2011)
Volume 36, Issue 6, Pages (June 2012)
Volume 19, Issue 3, Pages (September 2003)
Oral Tolerance Can Be Established via Gap Junction Transfer of Fed Antigens from CX3CR1+ Macrophages to CD103+ Dendritic Cells  Elisa Mazzini, Lucia Massimiliano,
Volume 38, Issue 6, Pages (June 2013)
Volume 34, Issue 3, Pages (March 2011)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 42, Issue 1, Pages (January 2015)
Volume 32, Issue 1, Pages (January 2010)
Volume 43, Issue 5, Pages (November 2015)
Volume 29, Issue 5, Pages (November 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 43, Issue 6, Pages (December 2015)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 29, Issue 1, Pages (July 2008)
Volume 31, Issue 6, Pages (December 2009)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
CD44 Regulates Survival and Memory Development in Th1 Cells
Volume 34, Issue 5, Pages (May 2011)
Volume 34, Issue 3, Pages (March 2011)
Volume 33, Issue 6, Pages (December 2010)
Volume 28, Issue 5, Pages (May 2008)
Volume 36, Issue 5, Pages (May 2012)
Volume 30, Issue 5, Pages (May 2009)
Volume 31, Issue 6, Pages (December 2009)
Volume 35, Issue 1, Pages (July 2011)
Volume 39, Issue 5, Pages (November 2013)
Volume 32, Issue 5, Pages (May 2010)
Volume 13, Issue 11, Pages (December 2015)
Volume 37, Issue 2, Pages (August 2012)
Volume 25, Issue 3, Pages (September 2006)
Volume 20, Issue 6, Pages (June 2004)
Presentation transcript:

Volume 34, Issue 2, Pages 237-246 (February 2011) Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria  Usriansyah Hadis, Benjamin Wahl, Olga Schulz, Matthias Hardtke-Wolenski, Angela Schippers, Norbert Wagner, Werner Müller, Tim Sparwasser, Reinhold Förster, Oliver Pabst  Immunity  Volume 34, Issue 2, Pages 237-246 (February 2011) DOI: 10.1016/j.immuni.2011.01.016 Copyright © 2011 Elsevier Inc. Terms and Conditions

Immunity 2011 34, 237-246DOI: (10.1016/j.immuni.2011.01.016) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 FoxP3+ Treg Cells Are Essential for the Maintenance of Oral Tolerance DEREG mice and nontransgenic wild-type littermates were either left untreated or tolerized by continuous application of Ova with the drinking water. Mice were injected with either DT or PBS as indicated. 14 days later, i.e., after restoration of normal FoxP3+ Treg cell frequencies, mice were primed one or two times with Ova in Alum and challenged every second day with Ova orally. Mice were scored positive for diarrhea when spontaneous diarrhea was observed after two consecutive challenges. Tolerized DEREG mice injected with DT were significantly more prone to diarrhea development compared to noninjected tolerized DEREG mice (1 × priming, p = 0.0401, one out of two experiments performed; 2 × priming p = 0.0259, one experiment performed); p values were determined by logrank test. Immunity 2011 34, 237-246DOI: (10.1016/j.immuni.2011.01.016) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Antigen-Specific FoxP3+ Treg Cells Accumulate in the Gut OT-II T cells were adoptively transferred to wild-type recipients, which received two oral doses of 50 mg Ova each. (A) Mice were analyzed 5 and 12 days after adoptive transfer. Plots are gated on Ly5.1+CD4+ cells. The frequency and total number of FoxP3+ Treg cells generated out of adoptively transferred OT-II Ly5.1+CD4+Vβ5.1+ cells was determined in pLN, mLN, and LP. Circles represent individual mice pooled from two independent experiments. (B) Plots are gated on CD4+FoxP3+ and depict adoptively transferred Ly5.1+ and recipient Ly5.2+ cells at day 5 as indicated. Please note plots in (B) are not gated on Vβ5.1, and Ly5.1+Helios+ cells in the LP might represent non-Ova-specific T cells. Plots display 10% probability contours, numbers indicate percentage gated cells. Immunity 2011 34, 237-246DOI: (10.1016/j.immuni.2011.01.016) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 FoxP3+ Treg Cells Proliferate in the Lamina Propria (A) Wild-type mice were adoptively transferred with OT-II T cells and received two oral doses of 50 mg Ova each. Groups I and II received BrdU with the drinking water starting with the first Ova gavage and were analyzed at day 5 and 12, respectively. Group III received Ova from day 5 until day 12. Treatment of the various groups of mice is depicted in the first panel with thick lines indicating the duration of BrdU application. The frequency of BrdU+ cells among adoptively transferred Ly5.1+CD4+FoxP3+ Treg cells was determined by flow cytometry. Circles represent individual mice analyzed pooled from two experiments. (B) Wild-type mice were injected with 1 mg BrdU i.p. and subsequently received BrdU with the drinking water for 2 or 48 hr. The frequency of BrdU+ cells among FoxP3+CD4+ (filled circles) and FoxP3−CD4+ (open diamonds) T cells was determined in pLN, mLN, spleen, and LP. Results were pooled from three independent experiments performed and symbols represent individual mice. Immunity 2011 34, 237-246DOI: (10.1016/j.immuni.2011.01.016) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Gut Homing Is Essential for Oral Tolerance (A) Oral tolerance was assessed in wild-type, ITGB7-, and MADCAM1-deficient mice. Circles represent individual mice pooled from two or more experiments. (B) FoxP3+ Treg cell generation was determined in MADCAM1-deficient mice by adoptive transfer experiments as described for Figure 2. Circles represent the frequency of FoxP3+ Treg cells generated from adoptively transferred OT-II Ly5.1+CD4+Vβ5.1+ cells in mLN of individual MADCAM1-deficient recipients. (C) 5 × 106 cells isolated from lymph nodes of OT-II mice were adoptively transferred to wild-type, ITGB7-, and MADCAM1-deficient mice and oral tolerance was assessed. Circles represent individual mice. Results in (B) and (C) were pooled from two experiments. Immunity 2011 34, 237-246DOI: (10.1016/j.immuni.2011.01.016) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 Reduced Frequency of IL-10-Producing F4/80+CD11b+MHCIIint Cells and Accumulation of FoxP3+ Treg Cells in the LP of CX3CR1-Deficient Mice (A) The number of F4/80+CD11b+ LP cells in wild-type and CX3CR1-deficient mice was determined by flow cytometry. Gates were set on live (DAPI−) CD45+ LP cells or F4/80+CD11b+ cells as indicated. Circles represent individual mice analyzed in two independent experiments. (B) LP cells were isolated, stimulated in vitro for 4 hr with PMA + ionomycin, and stained for intracellular IL-10. Representative FACS plots are shown. The diagram depicts the percentage of IL-10+ cells among F4/80+CD11b+ LP cells. Circles represent individual mice analyzed in two independent experiments. (C) The frequency of FoxP3+ Treg cells among adoptively transferred OT-II CD4+Ly5.1+Vβ5.1+ T cells was determined 5 days after transfer in mLN and LP and 12 days in pLN, mLN, and LP. Circles represent individual mice pooled from two to three independent experiments. Immunity 2011 34, 237-246DOI: (10.1016/j.immuni.2011.01.016) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 6 CX3CR1-Deficient Mice Fail to Mount Oral Tolerance (A) Oral tolerance was determined in CX3CR1-deficient mice on BALB/c (open circles) and C57BL/6 (closed circles) background compared to wild-type mice. Circles represent individual mice analyzed pooled from one (BALB/c) or two (C57BL/6) independent experiments. (B) Adherent cells were enriched from wild-type or CX3CR1-deficient donor spleens and 5 × 106 cells transferred to CX3CR1-deficient recipients on BALB/c (open circles) or C57BL/6 (filled circles) background prior to oral tolerance induction and assessment. Circles represent individual mice pooled from three experiments (C57BL/6) and one experiment (BALB/c). (C) Wild-type (solid lines) and CX3CR1-deficient mice on a BALB/c background (dashed lines) were either left untreated (squares) or tolerized by two consecutive doses of 50 mg Ova each (circles). Subsequently, mice were primed two times with Ova in Alum and challenged every second day with Ova orally as described for Figure 1. Mice were scored positive for diarrhea when spontaneous diarrhea was observed after two consecutive challenges. Tolerized CX3CR1-deficient mice were more prone to diarrhea development compared to tolerized wild-type mice (p = 0.0494), p values were determined by logrank test; results are representative of two experiments performed. Immunity 2011 34, 237-246DOI: (10.1016/j.immuni.2011.01.016) Copyright © 2011 Elsevier Inc. Terms and Conditions